IALP 2025

Validation and Reliability of the Japanese Version of the Speech Handicap Index

Jitsuro Yano 1 Dr. Tomonori Yokoyama 2 Mr. Daisuke Hara 3 Ms. Maya Nakahira 4 Prof. Hirotaka Hara 5 Dr. Isami Kumakura 6
1Department of Speech‑Language Pathology and Audiology, Faculty of Rehabilitation, Kawasaki University of Medical Welfare, Japan
2Division of Speech‑Language‑Hearing Therapy, Rehabilitation Center, Kawasaki Medical School General Medical Center, Japan
3Division of Rehabilitation, Nagoya University Hospital, Japan
4Department of Rehabilitation, Kochi Medical School Hospital, Japan
5Department of Otolaryngology-Head and Neck Surgery, Kawasaki Medical School, Japan
6Senri Rehabilitation Hospital, Japan

Purpose: This study aimed to validate the cross-cultural adaptation of the Japanese Speech Handicap Index (SHI-JP) for Japanese patients with speech disorders and assess its reliability.

Theoretical Background: Speech disorders often occur after head and neck cancer treatment or stroke. While perceptual ratings by clinicians are the gold standard, they fail to measure the impact on patients` quality of life. The SHI measures speech`s psychosocial impact in oral/pharyngeal cancer patients, yet no speech-specific questionnaire exists for Japanese speakers.

Research Method: The SHI-JP was given to 55 patients with oral/oropharyngeal cancer or neuromuscular disease and 68 healthy subjects. Content validity, construct validity, internal consistency, and test–retest reliability were evaluated. An unpaired t-test was used to compare scores between patients and healthy subjects to determine discriminatory ability.

Findings: The SHI-JP demonstrated high internal consistency (Cronbach’s α = 0.91) and test–retest reliability: total (T) 0.83, speech (S) 0.79, psychosocial (P) 0.81. Mean scores of SHI-JP for patient: 33.6 (T), 18.3 (S), 14.0 (P); healthy subject: 3.1 (T), 2.0 (S), 1.0 (P). The scores differed significantly between the groups (P < 0.001).

Discussion: The SHI-JP, adapted from the English SHI, is a culturally relevant, valid, and reliable tool to assess speech-related quality of life in Japanese-speaking patients.

Reference: 1) Rinkel, R. N., Verdonck-de Leeuw, I. M., van Reij, E. J., Aaronson, N. K., & Leemans, C. R. (2008). Speech Handicap Index in patients with oral and pharyngeal cancer: better understanding of patients` complaints. Head & neck, 30(7), 868–874. 2) Shiromoto, O., Oridate, N., Ikui Y., Taguchi A., Mizoguchi K., Watanabe Y., Tamura E., Omori K., & Yumoto E. (2014). Reliability and validity of the Japan Society of Logopedics and Phoniatrics version of VHI and VHI-10: a multi-center study. The Japan Society of Logopedics and Phoniatrics, 55(4), 291-298.